Company profile for Harbour BioMed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Harbour BioMed is a global clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics in oncology and immunological disease areas to address unmet patient needs. The Company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners, and select acquisitions....
Harbour BioMed is a global clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics in oncology and immunological disease areas to address unmet patient needs. The Company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners, and select acquisitions. The Company’s proprietary antibody technology platform Harbour Mice® generate fully human monoclonal antibodies in two heavy and two light chain (H2L2) format, as well as a heavy chain only (HCAb) format.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
22 Strathmore Rd, Suite 355, Natick, MA 01760
Telephone
Telephone
+1-617-6823679
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/harbour-biomed-advances-global-strategic-collaboration-with-astrazeneca-to-discover-and-develop-next-generation-biotherapeutics-in-oncology-302624117.html

PR NEWSWIRE
23 Nov 2025

https://www.businesswire.com/news/home/20251106194817/en/Evinova-China-and-Harbour-BioMed-Announce-Strategic-AI-Collaboration-to-Accelerate-AI-Enabled-Drug-Development

BUSINESSWIRE
07 Nov 2025

https://www.prnewswire.com/news-releases/harbour-biomed-launches-first-fully-human-generative-ai-hcab-model-to-accelerate-next-generation-biologics-discovery-302596961.html

PR NEWSWIRE
28 Oct 2025

https://www.prnewswire.com/news-releases/harbour-biomed-announces-positive-phase-ii-results-for-hbm4003-and-tislelizumab-combination-in-mss-mcrc-302589979.html

PR NEWSWIRE
22 Oct 2025

https://www.prnewswire.com/news-releases/harbour-biomed-reports-2025-interim-results-302540099.html

PR NEWSWIRE
27 Aug 2025

https://www.prnewswire.com/news-releases/harbour-biomed-appoints-yajie-li-as-chief-medical-officer-302537149.html

PR NEWSWIRE
25 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty